The short version of melanocortin receptor fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-04. Anything still debated is marked as such rather than presented as settled.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analog of alpha-melanocyte-stimulating hormone |
| Primary receptor family | Melanocortin receptors MC1R through MC5R | Binding is not subtype-selective |
| Development period | 1980s | Synthesized during pigmentation and appetite research |
| Regulatory status | Not an approved medicine | No major regulator has authorized human use |
| Related compound | Afamelanotide | Linear analog studied for photoprotection |
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
No specifics on the captured were given; Agence France-Presse stated that "Venezuela regularly claims to have arrested US-backed mercenaries working to destabilize Maduro's administration." Government officials announced in late October that surveillance cameras would be deployed at a large scale, and VenApp, an application used during the 2024 Venezuelan political crisis to enable citizens to report on each other's activities, would be reactivated to allow reporting to authorities of "everything they see and everything they hear, 24 hours a day". Venezuelan opposition leader María Corina Machado said the deployment encouraged "tens and tens of thousands" of Venezuelans to join an underground movement aiming to overthrow Maduro. Machado said that the 2024 Venezuelan presidential election gave a mandate for regime change, though she said that regime change was the responsibility of Venezuelans rather than of the US.
== Further reading == Slater, Anna G.; Cooper, Andrew I. (2015-05-29). "Function-led design of new porous materials". Science. 348 (6238) aaa8075. doi:10.1126/science.aaa8075. PMID 26023142. Satoh, Yusuke; Matsuno, Hirohiko; Yamamato, Takuya; Tajima, Kenji; Isono, Takuya; Satoh, Toshifumi (2017). "Synthesis of Well-Defined Three- and Four-Armed Cage-Shaped Polymers via "Topological Conversion" from Trefoil- and Quatrefoil-Shaped Polymers". Macromolecules. 50 (1): 97–106. Bibcode:2017MaMol..50...97S. doi:10.1021/acs.macromol.6b02316. Mato, Yoshinobu; Honda, Kohei; Tajima, Kenji; Yamamato, Takuya; Isono, Takuya; Satoh, Toshifumi (2019). "A versatile synthetic strategy for macromolecular cages: intramolecular consecutive cyclization of star-shaped polymers". Chemical Science. 10 (2): 440–446. doi:10.1039/C8SC04006K. PMC 6335864. PMID 30746091. Lee, Taeheon; Oh, Joongsuk; Jeong, Jonghwa; Jung, Haeji; Huh, June; Chang, Taihyun; Paik, Hyun-jong (2016-05-24). "Figure-Eight-Shaped and Cage-Shaped Cyclic Polystyrenes". Macromolecules. 49 (10): 3672–3680. Bibcode:2016MaMol..49.3672L. doi:10.1021/acs.macromol.6b00093. ISSN 0024-9297.
DNP raises energy expenditure by 30 to 40 percent and causes a weight loss of 0.7–0.9 kilograms (1.5–2.0 lb) per week. Although DNP is no longer in clinical use as a weight loss drug due to its dangerous side effects, its mechanism of action remains under investigation as a potential approach for treating obesity and non-alcoholic fatty liver disease. Researchers developed a prodrug, HU6, which is metabolized to DNP in the liver to provide more stable blood concentrations. HU6 completed a phase II trial in which it produced significant reductions in liver fat and body weight in overweight people with elevated liver fat, without serious adverse effects. DNP is used by bodybuilders, fitness enthusiasts, and people with an eating disorder to lose weight. The user profile is similar to that of anabolic steroids; many perceive it to be effective and with manageable risks. Despite health warnings from regulators, DNP is readily available online sometimes under other names such as Dinosan, Dnoc, Solfo Black, Nitrophen, Aldifen, and Chemox. DNP is often sold in tablets containing 100 to 200 mg and may be sold alongside other substances such as anabolic steroids and thyroxine. It may also be found as a contaminant in other bodybuilding supplements not advertised as containing DNP. Online message boards provide information on dosage and regimens for DNP use, and describe the risks of taking the compound and provide advice on how to mitigate hyperthermia. According to a study published in 2023, the most commonly reported doses were between 150 to 300 mg/d.
On 27 November, Otago firefighters experienced four equipment failures including a broken down command truck while responding to lcoal vegetation fires. 29 November: Air New Zealand and Jetstar temporarily ground their Airbus A320neo jets in response to a technical glitch caused by solar radiation. Several flights are disrupted nationwide. Stuff journalist Andrea Vance reports that an attempt by Chris Bishop to roll Christopher Luxon has failed. The Waitangi Tribunal rules that the New Zealand government's decision to exclude the Treaty of Waitangi from a draft geothermal energy agreement would constitute a Treaty breach.
=== Column === The column is a glass or plastic cylinder packed with beads of resin and filled with buffer solution. It is normally mounted vertically with the buffer flowing downward from top to bottom. A glass frit at the bottom of the column retains the resin beads in the column while allowing the buffer and dissolved proteins to exit.
Sources: en.wikipedia.org
==== X-ray intensifier foils ==== In the same year as the discovery of X-rays, Mihajlo Idvorski Pupin (1858-1935) invented the method of placing a sheet of paper coated with fluorescent substances on the photographic plate, drastically reducing the exposure time and thus the radiation exposure. 95% of the film was blackened by the intensifying film and only the remaining 5% was directly blackened by the X-rays. Thomas Alva Edison identified the blue-emitting calcium tungstate (CaWO4) as a suitable phosphor, which quickly became the standard for X-ray intensifying film. In the 1970s, calcium tungstate was replaced by even better and finer intensifying films with rare earth-based phosphors (terbium-activated lanthanum oxybromide, gadolinium oxysulfide). The use of intensifying films in dental film production did not become widespread because of the loss of image quality. The combination with high-sensitivity films further reduced radiation exposure.
Kenner's work was recognised by the awards of the Meldola Medal (1951) and the Corday-Morgan Medal (1957) and in distinguished lectureships such as Tilden (1955), Simonsen (1972) and Pedler (1976) of the Chemical Society of whose Perkin Division he was President from 1974 to 1976. He was also President of Section B of the British Association for the Advancement of Science in 1974. Elected a Fellow of the Royal Society in 1964 he was the Society's Bakerian Lecturer for 1976 and was elected to a Royal Society Research Professorship in 1976.
== Mechanism == Biochemical and structural analyses of aminopeptidase (APPro), methionine aminopeptidase (MetAP), and prolidase, all members of the "pita-bread" metalloenzymes, suggest that they share a common mechanism scheme. The main difference arises in the location of the carbonyl oxygen atom of the scissile peptide bond.
=== Senior team === Townsend's first call-up to the senior England squad came in September 2013, for the World Cup qualifiers against Moldova and Ukraine. He made his senior debut against Montenegro in a World Cup qualifier on 11 October, during which he scored the third goal of a 4–1 win with a "low swerving finish" from outside the penalty area after 78 minutes, two minutes before being substituted, and was named man of the match. He earned a second cap four days later against Poland, playing almost all of the 2–0 home win. A second England goal came in the Euro 2016 qualification campaign in a 5–0 win over San Marino on 9 October 2014, as he came on for the final third of the match. His next appearance marked his third England goal; on 31 March 2015 he scored the equaliser in the 79th minute against Italy, having come on seven minutes earlier in a friendly match which ended 1–1. The 20-yard strike was described as a "sweet right-foot drive into the bottom corner"; Townsend took to Twitter immediately after the match to respond to Paul Merson after he had said Townsend's club form did not justify him being in the England team.
Sources: en.wikipedia.org
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.
Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.
A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.